HZA106829: A Randomised, Double-blind, Parallel Group, Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder, Fluticasone Furoate Inhalation Powder Alone, and Fluticasone Propionate Alone in the Treatment of Persistent Asthma in Adults and Adolescents.
Phase of Trial: Phase III
Latest Information Update: 24 May 2017
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone furoate; Fluticasone propionate
- Indications Asthma
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 24 May 2017 Results of a post-hoc analysis from NCT01165138, NCT01686633 and NCT01134042 trials presented at the 113th International Conference of the American Thoracic Society
- 17 Oct 2013 Results published in the European Respiratory Journal.
- 26 Apr 2012 Actual patient number (587) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History